We hold this company’s filings and have not read the financial statements out of them yet. Every filing on record is listed under filings, and each one opens.
Earnings calls
3 transcript(s)/analyst meet(s) served; 0 document(s) on file are not transcripts (cover letters, duplicates, unresolved) and are excluded. Speaker attribution is shown only where the segmenter attributes ≥ 95% of sentences to management or analysts (0 of 3 documents here); elsewhere sentences render unattributed.
Kind
Date
Period
Served
Attribution rate
TRANSCRIPT
20210512
2021-03-31
yes
TRANSCRIPT
20210513
2021-03-31
yes
TRANSCRIPT
20231116
2024-03-31
yes
TRANSCRIPT
20240521
2024-03-31
yes
TRANSCRIPT
20240802
2024-06-30
yes
TRANSCRIPT
20241113
2024-09-30
yes
TRANSCRIPT
20250819
2025-06-30
yes
TRANSCRIPT
20251119
2025-09-30
yes
TRANSCRIPT
20260128
2025-12-31
yes
TRANSCRIPT
20260505
2026-03-31
yes
TRANSCRIPT
20260727
2026-06-30
yes
GRANULES
files the standard Schedule III statements. Every figure below opens to the filing it was read from; where a figure is not shown, the reason is printed in its place.
Identity
Statement division
general
Scope served
consolidated
Panels on this page
4
Market
No split, bonus or consolidation is on record for this company inside the period this price series covers, so the closes need no adjustment.
Last close
853.00
52-week range
514.6 – 909.3
Return 1M
0.83%
Return 3M
11.62%
Return 1Y
60.7%
Return 3Y
155.58%
Return 5Y
165.07%
Market capitalisation
not shown — we could not confirm it
Shares outstanding
not shown — we could not confirm it
P/E
not shown — we could not confirm it
P/B
not shown — we could not confirm it
EV/EBITDA
not shown — we could not confirm it
Latest quarter filed — period ending 2026-06-30
In INR crore except per-share figures. `period_id` is the period the filing names for the number; the date beside each cell is when it was filed.
Revenue from operations
1,477.00
Other income
2.00
Total income
1,479.00
Cost of materials consumed
496.00
Purchases of stock-in-trade
0.00
Changes in inventories
12.00
Employee benefit expense
255.00
Finance costs
21.00
Ownership — 2026-06-30, and the change from 2026-03-31
Holder
Per cent
Change
promoter and promoter group
0.38
0.00
institutions foreign
0.17
0.02
institutions domestic
0.16
-0.01
mutual funds
0.03
0.01
public
0.62
0.00
Documents on file
Class
Most recent
On file
TRANSCRIPT
2026-06-30
11
Financial statements
Filed results, consolidated, in INR crore except per-share figures. Every figure opens to the filing it was read from. Quarterly and annual columns are the periods the filing itself names, never a document date.
Quarterly results, as filed
Line
2022-09-30
2022-12-31
2023-03-31
2023-06-30
2023-09-30
2023-12-31
2024-03-31
2024-06-30
2024-09-30
2024-12-31
2025-03-31
2025-06-30
2025-09-30
2025-12-31
2026-03-31
2026-06-30
Revenue from operations
1,151.00
1,146.00
1,196.00
986.00
1,189.00
1,156.00
1,176.00
1,180.00
967.00
1,138.00
1,197.00
1,210.00
1,297.00
1,388.00
1,471.00
1,477.00
Other income
5.00
1.00
3.00
0.00
2.00
1.00
2.00
2.00
3.00
6.00
2.00
16.00
-1.00
-4.00
9.00
2.00
Total income
1,156.00
1,147.00
1,199.00
986.00
1,191.00
1,156.00
1,178.00
1,182.00
970.00
1,143.00
1,199.00
1,226.00
1,296.00
1,384.00
1,479.00
1,479.00
Cost of materials consumed
618.00
594.00
604.00
589.00
520.00
553.00
547.00
483.00
362.00
445.00
435.00
429.00
498.00
529.00
644.00
496.00
Purchases of stock-in-trade
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Changes in inventories
-40.00
-2.00
19.00
-109.00
55.00
-56.00
-77.00
1.00
5.00
-9.00
4.00
-3.00
-53.00
-28.00
-140.00
12.00
Employee benefit expense
118.00
119.00
127.00
140.00
149.00
157.00
152.00
164.00
159.00
168.00
169.00
203.00
219.00
226.00
240.00
255.00
Finance costs
13.00
17.00
19.00
22.00
26.00
29.00
29.00
27.00
26.00
27.00
24.00
24.00
29.00
29.00
33.00
21.00
Depreciation and amortisation
44.00
48.00
49.00
49.00
53.00
52.00
53.00
53.00
53.00
57.00
63.00
69.00
72.00
74.00
82.00
80.00
Other expenses
212.00
204.00
217.00
229.00
253.00
251.00
299.00
273.00
237.00
304.00
338.00
336.00
355.00
352.00
374.00
375.00
Total expenses
965.00
980.00
1,035.00
920.00
1,055.00
986.00
1,002.00
1,000.00
841.00
991.00
1,033.00
1,056.00
1,120.00
1,182.00
1,233.00
1,239.00
Profit before exceptional items and tax
190.00
167.00
164.00
65.00
136.00
170.00
176.00
181.00
128.00
153.00
167.00
170.00
176.00
202.00
246.00
240.00
Exceptional items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
31.00
-26.00
0.00
0.00
16.00
0.00
Profit before tax
190.00
167.00
164.00
65.00
136.00
170.00
176.00
181.00
128.00
153.00
198.00
145.00
176.00
202.00
262.00
240.00
Current tax
38.00
51.00
47.00
26.00
36.00
54.00
49.00
53.00
31.00
37.00
62.00
38.00
51.00
73.00
34.00
65.00
Deferred tax
8.00
-8.00
-3.00
-8.00
-2.00
-10.00
-3.00
-6.00
-0.00
-2.00
-16.00
-6.00
-6.00
-21.00
27.00
-4.00
Tax expense
45.00
43.00
44.00
18.00
34.00
44.00
46.00
47.00
31.00
35.00
46.00
32.00
45.00
52.00
61.00
60.00
Profit for the period
145.00
124.00
120.00
48.00
102.00
126.00
130.00
135.00
97.00
118.00
152.00
113.00
131.00
150.00
202.00
180.00
Profit attributable to owners
145.00
124.00
120.00
—
—
126.00
139.00
135.00
97.00
118.00
152.00
110.00
131.00
150.00
—
180.00
Profit attributable to non-controlling interests
—
—
0.00
—
—
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
—
0.00
Other comprehensive income
37.00
-9.00
2.00
0.00
16.00
-5.00
9.00
2.00
4.00
10.00
11.00
19.00
39.00
19.00
66.00
30.00
Total comprehensive income
182.00
115.00
121.00
48.00
118.00
121.00
139.00
137.00
101.00
128.00
163.00
132.00
170.00
169.00
268.00
210.00
Earnings per share, basic
5.85
5.11
4.94
1.98
4.22
5.18
5.35
5.56
4.01
4.85
6.27
4.64
5.38
6.19
8.23
7.26
Earnings per share, diluted
5.82
5.10
4.93
1.98
4.22
5.18
5.35
5.55
4.01
4.85
6.27
4.64
5.38
6.19
8.23
7.12
Annual results, as filed
Line
2019-03-31
2020-03-31
2021-03-31
2022-03-31
2023-03-31
2024-03-31
2025-03-31
2026-03-31
Revenue from operations
2,279.00
2,599.00
3,238.00
3,765.00
4,512.00
4,506.00
4,482.00
5,366.00
Other income
27.00
37.00
27.00
18.00
14.00
4.00
13.00
20.00
Total income
2,306.00
2,635.00
3,264.00
3,783.00
4,526.00
4,511.00
4,495.00
5,386.00
Cost of materials consumed
1,339.00
1,315.00
1,590.00
2,036.00
2,353.00
2,208.00
1,725.00
2,100.00
Purchases of stock-in-trade
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Changes in inventories
-83.00
-34.00
-199.00
-153.00
-45.00
-187.00
1.00
-224.00
Employee benefit expense
210.00
259.00
408.00
401.00
472.00
598.00
660.00
888.00
Finance costs
28.00
27.00
26.00
23.00
56.00
106.00
103.00
114.00
Depreciation and amortisation
105.00
137.00
151.00
159.00
184.00
207.00
226.00
296.00
Other expenses
430.00
533.00
583.00
758.00
819.00
1,031.00
1,151.00
1,416.00
Total expenses
2,029.00
2,237.00
2,560.00
3,225.00
3,839.00
3,964.00
3,865.00
4,591.00
Profit before exceptional items and tax
277.00
398.00
704.00
558.00
687.00
547.00
629.00
795.00
Exceptional items
0.00
28.00
0.00
0.00
0.00
0.00
31.00
-10.00
Profit before tax
277.00
426.00
704.00
558.00
687.00
547.00
660.00
785.00
Current tax
82.00
126.00
195.00
138.00
177.00
165.00
183.00
196.00
Deferred tax
7.00
-10.00
-40.00
7.00
-7.00
-23.00
-24.00
-6.00
Tax expense
89.00
116.00
155.00
145.00
171.00
142.00
159.00
190.00
Profit for the period
236.00
335.00
549.00
413.00
517.00
405.00
502.00
595.00
Profit attributable to owners
0.00
0.00
—
413.00
517.00
426.00
502.00
—
Profit attributable to non-controlling interests
0.00
0.00
—
0.00
0.00
0.00
0.00
—
Other comprehensive income
13.00
2.00
-26.00
40.00
57.00
20.00
27.00
143.00
Total comprehensive income
249.00
338.00
523.00
453.00
574.00
426.00
529.00
738.00
Earnings per share, basic
9.30
13.19
22.05
16.66
21.05
16.73
20.69
24.47
Earnings per share, diluted
9.28
13.15
21.95
16.60
21.00
16.72
20.68
24.46
Balance sheet, as filed
Line
2022-09-30
2023-03-31
2023-09-30
2024-03-31
2024-09-30
2025-03-31
2025-09-30
2026-03-31
Total assets
4,858.00
4,905.00
5,265.00
5,521.00
5,433.00
6,253.00
6,944.00
7,720.00
Non-current assets
2,130.00
2,330.00
2,473.00
2,616.00
2,827.00
3,137.00
3,857.00
3,952.00
Current assets
2,729.00
2,574.00
2,792.00
2,905.00
2,605.00
3,115.00
3,087.00
3,768.00
Property, plant and equipment
1,431.00
1,631.00
1,787.00
1,856.00
1,893.00
2,217.00
2,612.00
3,051.00
Capital work-in-progress
297.00
228.00
219.00
260.00
411.00
437.00
702.00
406.00
Goodwill
0.00
0.00
0.00
0.00
0.00
0.00
12.00
12.00
Other intangible assets
266.00
280.00
260.00
240.00
224.00
209.00
189.00
187.00
Inventories
1,163.00
1,149.00
1,280.00
1,301.00
1,395.00
1,343.00
1,488.00
1,673.00
Trade receivables
846.00
949.00
1,016.00
986.00
727.00
942.00
761.00
909.00
Cash and cash equivalents
395.00
292.00
295.00
381.00
209.00
466.00
609.00
880.00
Total equity and liabilities
4,858.00
4,905.00
5,265.00
5,521.00
5,433.00
6,253.00
6,944.00
7,720.00
Equity
2,598.00
2,835.00
2,967.00
3,226.00
3,427.00
3,716.00
3,983.00
5,085.00
Equity share capital
25.00
24.00
24.00
24.00
24.00
24.00
24.00
25.00
Other equity
2,573.00
2,811.00
2,943.00
3,201.00
3,403.00
3,691.00
3,959.00
5,060.00
Total liabilities
2,260.00
2,070.00
2,297.00
2,295.00
2,005.00
2,537.00
2,961.00
2,635.00
Non-current liabilities
242.00
256.00
228.00
213.00
314.00
534.00
544.00
543.00
Current liabilities
2,017.00
1,814.00
2,069.00
2,082.00
1,692.00
2,003.00
2,417.00
2,092.00
Borrowings, non-current
177.00
149.00
98.00
69.00
157.00
312.00
318.00
297.00
Borrowings, current
883.00
910.00
1,187.00
1,154.00
853.00
974.00
1,320.00
1,041.00
Trade payables
707.00
782.00
729.00
750.00
635.00
726.00
755.00
673.00
Cash flow, as filed
Line
2022-09-30
2023-03-31
2023-09-30
2024-03-31
2024-09-30
2025-03-31
2025-09-30
2026-03-31
Net cash from operating activities
398.00
739.00
36.00
439.00
417.00
867.00
474.00
793.00
Net cash from investing activities
-112.00
-191.00
-170.00
-360.00
-279.00
-691.00
-499.00
-773.00
Net cash from financing activities
-76.00
-440.00
136.00
8.00
-311.00
-93.00
159.00
379.00
Purchase of property, plant and equipment
176.00
411.00
177.00
381.00
277.00
572.00
325.00
558.00
Net increase in cash
210.00
107.00
4.00
90.00
-172.00
85.00
142.00
412.00
con:CFO.BEFORE_TAX
482.00
915.00
112.00
630.00
478.00
1,010.00
563.00
1,033.00
con:INTEREST_RECEIVED.OPERATING
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
con:INTEREST_PAID.OPERATING
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
con:DIVIDENDS_RECEIVED.OPERATING
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
con:TAX_PAID.OPERATING
84.00
176.00
76.00
190.00
61.00
144.00
89.00
240.00
con:CF_OTHER.OPERATING
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
con:INVESTMENTS_PURCHASED
0.00
0.00
0.00
0.00
0.00
0.00
198.00
0.00
con:INVESTMENTS_SOLD
0.00
0.00
0.00
0.00
0.00
0.00
0.00
32.00
con:PPE_DISPOSALS
0.00
0.00
1.00
2.00
0.00
0.00
0.00
4.00
con:CF_INVESTING.SUBSIDIARIES_SOLD
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
con:CF_INVESTING.SUBSIDIARIES_ACQUIRED
0.00
0.00
0.00
0.00
0.00
0.00
0.00
198.00
con:CF_INVESTING.JV_SOLD
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
con:CF_INVESTING.JV_ACQUIRED
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Who owns it
The shareholding pattern filed with the exchange every quarter, as a series. Percentages are of total shares. Each figure names the filing it was read from and the date it was filed.
Holder
2023-03-31
2023-06-30
2023-09-30
2023-12-31
2024-03-31
2024-06-30
2024-09-30
2024-12-31
2025-03-31
2025-09-30
2025-12-31
2026-02-23
2026-03-31
2026-06-30
Promoter and promoter group
42.02
42.02
41.96
41.96
41.96
38.87
38.87
38.85
38.84
0.39
0.39
0.38
0.38
0.38
Domestic institutions
5.03
6.68
7.06
10.16
10.70
14.12
14.87
19.57
22.45
0.18
0.17
0.19
0.17
0.16
Mutual funds
—
—
—
—
—
—
—
—
—
0.07
0.05
0.04
0.03
0.03
Insurance companies
1.27
1.81
2.92
3.09
3.59
4.69
6.12
8.44
10.13
0.11
0.11
0.10
0.10
0.09
Foreign institutions
23.90
21.35
21.48
18.78
19.57
20.39
19.49
15.87
15.15
0.14
0.14
0.14
0.15
0.17
Public
57.98
57.98
58.04
58.04
58.04
61.13
61.13
61.15
61.16
0.61
0.61
0.62
0.62
0.62
Non-institutional
29.05
29.95
29.50
29.10
27.76
26.62
26.78
25.71
23.57
0.29
0.30
0.30
0.30
0.28
Shares outstanding
242042756
242042756
242368716
242368716
242368716
242368716
242368716
242493716
242543716
242668716
242668716
247796921
247796921
247796921
Related parties
Transactions with related parties as disclosed to the exchange for the period ending 2024-09-30, by counterparty, largest first. Amounts are as filed. Each row names the filing and the date it was filed.
Counterparty
Relationship
Type
Amount in the period
Transactions
Granules Consumer Health Inc
Step down subsidiary
Any other transaction, Loan, Purchase of goods or se
3,730,560,000.00
13
Granules Pharmaceuticals Inc
Subsidiary
Any other transaction, Investment, Purchase of goods
3,294,180,000.00
9
Granules Life Sciences Pvt Ltd
Subsidiary
Any other transaction, Investment, Purchase of goods
1,686,470,000.00
9
Granules USA Inc
Subsidiary
Any other transaction, Investment, Purchase of goods
912,030,000.00
13
Product Armor Packaging Pvt Ltd
Enterprises over which key managem
Any other transaction, Purchase of goods or services
213,450,000.00
4
Granules CZRO Pvt Ltd
Subsidiary
Any other transaction, Investment
202,710,000.00
4
Dr. Krishna Prasad Chigurupati
Key Management Personnel
Any other transaction
101,920,000.00
1
Dr. K.V.S. Ram Rao
Key Management Personnel
Any other transaction
41,810,000.00
1
Granules Europe Ltd
Subsidiary
Any other transaction, Investment, Loan
38,940,000.00
4
Key Management Personnel
Key Management Personnel
Any other transaction
28,030,000.00
1
Granules Trust
Enterprises over which key managem
Any other transaction
25,000,000.00
1
Mrs. Uma Devi Chigurupati
Key Management Personnel
Any other transaction
10,190,000.00
1
Mr. Harsha Chigurupati
Key Management Personnel
Any other transaction
10,190,000.00
1
Mrs. Priyanka Chigurupati
Key Management Personnel
Any other transaction
10,190,000.00
1
Non Executive Directors
Non Executive Director
Any other transaction
8,470,000.00
1
What management said
Every earnings call we hold for this company, read in full. Prepared remarks are separated from the question-and-answer session and every paragraph names who said it and on which page. These are management’s own words, not filed figures.
The contracts that we are entering in right now, are those kind of a fixed price contract in terms of we'll buy at certain price because they will als…
CAPEX spend during the quarter was 1029 million.
Capital allocation
—
So, do we have any dividend policy in the company?
Costs
Sudarshan Padmanabhan Sundaram Asset Management Company Ltd. - Research Analyst My question is to understand a little bit more about the raw material …
Price erosions were offset by the reduction in rates of key raw materials.
Debt and cash
Our operational cash flow for the year at INR 432 crores versus INR 476 crores in the previous year, mainly on account of increase in working capital …
Granules India Limited November 09, 2023 Our net debt was 9895 million as compared to 7671 million at the beginning of the year.
Demand
—
So, what exactly is driving this, are there some specific launches or it’s the general pricing and demand environment that we are seeing in that marke…
Guidance
They're moving to a new site, and we expect this to start in the next 2 or 3 quarters.
Significant progress has happened on these dosage forms, and we expect to file new dosage forms in the near future.
Margin
Anil Sarin Centrum Wealth Management Limited - Executive Director & CIO-Centrum PMS Congratulations on an actually elevated margin despite the PAP pro…
EBITDA for the quarter was, Rs.2130 million, 17.9% of sales as compared to 2429 million, 21.1% of sales in Q2 FY23, a decrease of 12% in value terms o…
Pricing
So we can partially pass on the price increases.
And there are some changes that I mentioned earlier in my discussion that have happened in the market, which have enabled us to pick up more market sh…
Revenue growth
So what we are saying is 20% revenue growth.
The second quarter revenue were Rs.11,895 million as compared to 11,507 million in Q2 FY23. A growth of 3% in value terms.
What they said they would do
Sentences in which management set an expectation. Each names the speaker and the page of the transcript it came from.
Date
Quarter
Who
What they said
2021-05-13
FYFY21
Operator
Krishna Prasad Chigurupati Granules India Limited - Chairman & MD For the current fiscal, we expect that the growth – the EBITDA also will be around 20% and growth also over the base of '21 will be 20%. * (please see note above) Tushar Manudhane Motilal Oswal Securities Limited, Research Division - Research Analyst And the scope of passing on the raw material price hike to the customers, how do we see that changing?
2021-05-13
FYFY21
Operator
So our guidance of 30% EBITDA margin, does that assume significant deflation in PAP prices in, let's say, quarter 3 or quarter 4?